Volume 20 • Issue 3 February 5, 2020
Pharmadirect Logo News
 

BUSCOPAN® LAUNCHES A 20 TABLET BLISTER PACK

 

Buscopan®, a targeted antispasmodic treatment for patients suffering from abdominal cramps, pain & discomfort, is now offered in a convenient blister pack format, available to patients without prescription.
READ MORE

 

UPDATE TO SATIVEX® PRODUCT MONOGRAPH

 

The Product Monograph for Sativex® (delta-9-tetrahydrocannabinol 27mg/mL and cannabidiol 25mg/mL, buccal spray) has been recently updated.
READ MORE

 

SOLIQUA®: NOW REIMBURSED UNDER THE ODB FORMULARY

 

SOLIQUA® (insulin glargine/lixisenatide) is now reimbursed as a general benefit under the ODB Formulary.
READ MORE

 

NEW – BAQSIMI: NOW AVAILABLE IN CANADA

 

In a severe hypoglycemia emergency, BAQSIMI, a portable dry nasal powder glucagon, is comparable in efficacy to injectable glucagon and successfully administered by trained and untrained persons. DIN: 02492415 UPC: 773007000730.
READ MORE

PRODUCT AWARENESS

 

INTRODUCING PRESERVATIVE-FREE BIOTRUE® EYE DROPS

 

With up to 2.4 mg/mL of sodium hyaluronate, Biotrue® Eye Drops are clinically proven to provide long-lasting relief for dry eye symptoms. Available in single dose vials or in an innovative multi-dose system.
READ MORE

 

HOW COLD-FX® DAILY SUPPORT AND THE FLU SHOT ARE PROVEN BETTER TOGETHER

 

COLD-FX® Daily Support and the flu shot provide further reduction of cold and flu symptoms…
READ MORE

 

NATURALLY SOURCED COLD SORE TREATMENT

 

Speeds healing of cold sores by an average of…
READ MORE

Classifieds
Classifieds